FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Matthew Volm

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Genes & Molecular Sequences

Genes, erbB-2

Co-author Network

Publications

TOP 3
Eleni Andreopoulou; Darci Gaiotti; Eugene Kim; Matthew Volm; Ruth Oratz; Robin Freedberg; Andrea Downey; Charles L Vogel; Stephen Chia; Franco Muggia
Feasibility and cardiac safety of pegylated liposomal doxorubicin plus trastuzumab in heavily pretreated patients with recurrent HER2-overexpressing metastatic breast cancer.
Jonathan D Schwartz; Max Sung; Myron Schwartz; Deborah Lehrer; John Mandeli; Leonard Liebes; Alec Goldenberg; Matthew Volm
Thalidomide in advanced hepatocellular carcinoma with optional low-dose interferon-alpha2a upon progression.
Missak Haigentz; Mimi Y Kim; Joan Sorich; Janet Lee; Howard Hochster; Manuel Macapinlac; Deepu Mirchandani; Sanjeev Sewak; Anna Pavlick; Matthew Volm; Anne Hamilton; Franco M Muggia
Phase I study of amifostine as a cytoprotector of the gemcitabine/cisplatin combination in patients with advanced solid malignancies.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Matthew Volm (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Eleni Andreopoulou; Darci Gaiotti; Eugene Kim; Matthew Volm; Ruth Oratz; Robin Freedberg; Andrea Downey; Charles L Vogel; Stephen Chia; Franco Muggia
Feasibility and cardiac safety of pegylated liposomal doxorubicin plus trastuzumab in heavily pretreated patients with recurrent HER2-overexpressing metastatic breast cancer.
Clinical breast cancer 2007;7(9):690-6.
2005: Jonathan D Schwartz; Max Sung; Myron Schwartz; Deborah Lehrer; John Mandeli; Leonard Liebes; Alec Goldenberg; Matthew Volm
Thalidomide in advanced hepatocellular carcinoma with optional low-dose interferon-alpha2a upon progression.
The oncologist 2005;10(9):718-27.
2003: Missak Haigentz; Mimi Y Kim; Joan Sorich; Janet Lee; Howard Hochster; Manuel Macapinlac; Deepu Mirchandani; Sanjeev Sewak; Anna Pavlick; Matthew Volm; Anne Hamilton; Franco M Muggia
Phase I study of amifostine as a cytoprotector of the gemcitabine/cisplatin combination in patients with advanced solid malignancies.
Anti-cancer drugs 2003;14(4):321-6.
2003: Silvia C Formenti; Matthew Volm; Kristin A Skinner; Darcy Spicer; Deidre Cohen; Edith Perez; Anna C Bettini; Susan Groshen; Conway Gee; Barbara D Florentine; Michael F Press; Peter V Danenberg; Franco Muggia
Preoperative twice-weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin-based chemotherapy in locally advanced breast cancer: a phase I/II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(5):864-70.
2001: Sandra Demaria; Matthew Volm; Richard L Shapiro; Herman T Yee; Ruth Oratz; Silvia C Formenti; Franco Muggia; WF Symmans
Development of tumor-infiltrating lymphocytes in breast cancer after neoadjuvant paclitaxel chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(10):3025-30.
2001: Beata Holkova; Kenichi Takeshita; D M Cheng; Matthew Volm; Carolyn Wasserheit; Rita Demopoulos; Asher Chanan-Khan
Effect of highly active antiretroviral therapy on survival in patients with AIDS-associated pulmonary Kaposi's sarcoma treated with chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(18):3848-51.
2001: Anne Hamilton; Matthew Volm
Nonsteroidal and steroidal aromatase inhibitors in breast cancer.
Oncology (Williston Park, N.Y.) 2001;15(8):965-72; discussion 972, 977-9.
2000: WF Symmans; Matthew Volm; Richard L Shapiro; A B Perkins; A Y Kim; Sandra Demaria; Herman T Yee; HF McMullen; Ruth Oratz; P Klein; Silvia C Formenti; Franco Muggia
Paclitaxel-induced apoptosis and mitotic arrest assessed by serial fine-needle aspiration: implications for early prediction of breast cancer response to neoadjuvant treatment.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(12):4610-7.
1999: Silvia C Formenti; W F Symmans; Matthew Volm; Kristin Skinner; Deidre Cohen; Darcy Spicer; Peter V Danenberg
Concurrent paclitaxel and radiation therapy for breast cancer.
Seminars in radiation oncology 1999;9(2 Suppl 1):34-42.
1998: J O'Leary; Matthew Volm; Carolyn Wasserheit; Franco Muggia
Taxanes in adjuvant and neoadjuvant therapies for breast cancer.
Oncology (Williston Park, N.Y.) 1998;12(1 Suppl 1):23-7.
1997: Elissa L Kramer; Matthew Volm; B Donahue; Carolyn Wasserheit; J Chapnick; J Sanger; M Koslow
Tc-99m LL-2 Fab' monoclonal antibody imaging in acquired immune deficiency syndrome-related lymphoma.
Cancer 1997;80(12 Suppl):2469-77.